Dr. Fernando Martinez has joined Alvotech as the Head of our new integration effort, the establishment of a specialty Contracted Development & Manufacturing Organization (CDMO) leveraging Alvotech’s state-of-the-art infrastructure and expertise.
Fernando is joining Alvotech from Covance, where he led the interventional peri-post approval and RWE clinical research business. Prior to that, he held global executive roles in several market-leading CROs, with responsibilities ranging across Corporate and Business Development, Strategic Alliances & M&A, and the management of clinical research staff in traditional and emerging markets.
Fernando sits on the board of ACRP, the world’s largest association of clinical research professionals and is frequently invited to speak at renowned international conferences.
Fernando holds a PhD in Medicinal Chemistry from the University of Bristol (United Kingdom), as well as an MBA from Universidad Politécnica de Madrid. He received his MSc. from the Westfälische Wilhelms-Universität Münster (Germany).